A Phase 1/2A Study of LAM561 in Adult Patients With Advanced Solid Tumours

NCT01792310 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioma
Other Solid Tumours

Interventions

DRUG: LAM561

Sponsor

Laminar Pharmaceuticals

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]